Hendrik's Chronic Coronary Artery Disease Journey
Follow Hendrik on his Chronic Coronary Artery Disease Journey
1Vaduganathan M, et al. The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. J Am Coll Cardiol. 2022 Dec 20;80(25):2361-2371. doi: 10.1016/j.jacc.2022.11.005.2) https://world-heart-federation.org/what-is-cvd/
2https://world-heart-federation.org/what-is-cvd/
3https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/symptoms-causes/syc-20350613
4Data for CAD based on “clarivate 2022”; number of procedures in the year 2022
5Within physical limits
6Dose reduction (based on phantom measurement) compared to conventional automatic exposure control, e.g. available with Artis Q, image quality is defined by contrast-to noise ratio
7Not only for vFFR
8Masdjedi K, et al. Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study. EuroIntervention 2022 Apr 22;17(18):1498-1505. doi: 10.4244/EIJ-D-21-00471
9Hagar MT, et al. Accuracy of Ultrahigh-Resolution Photon-counting CT for Detecting Coronary Artery Disease in a High-Risk Population. Radiology. 2023 Jun;307(5):e223305, download: https://doi.org/10.1148/radiol.223305
10NAEOTOM Alpha is not commercially available in all regions. It's future availability cannot be guaranteed.
11McBeath K, et al. Improved clinical outcomes post percutaneous coronary intervention (PCI) with the use of an enhanced visualisation system (CLEARstent) [Internet]. Eur. Heart J. 2018 Aug 18;39(1) [cited 2023 Jun 13]. Available at: https://doi.org/10.1093/eurheartj/ehy566.P5500
Image courtesy
Courtesy of Erasmus University Medical Center, Rotterdam
Courtesy of Erasmus University Medical Center, Rotterdam